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Malaria transmission in Madagascar is highly heterogeneous, exhibiting spatial, seasonal and long‑
term trends. Previous efforts to map malaria risk in Madagascar used prevalence data from Malaria 
Indicator Surveys. These cross‑sectional surveys, conducted during the high transmission season most 
recently in 2013 and 2016, provide nationally representative prevalence data but cover relatively short 
time frames. Conversely, monthly case data are collected at health facilities but suffer from biases, 
including incomplete reporting and low rates of treatment seeking. We combined survey and case data 
to make monthly maps of prevalence between 2013 and 2016. Health facility catchment populations 
were estimated to produce incidence rates from the case data. Smoothed incidence surfaces, 
environmental and socioeconomic covariates, and survey data informed a Bayesian prevalence 
model, in which a flexible incidence‑to‑prevalence relationship was learned. Modelled spatial trends 
were consistent over time, with highest prevalence in the coastal regions and low prevalence in the 
highlands and desert south. Prevalence was lowest in 2014 and peaked in 2015 and seasonality was 
widely observed, including in some lower transmission regions. These trends highlight the utility of 
monthly prevalence estimates over the four year period. By combining survey and case data using this 
two‑step modelling approach, we were able to take advantage of the relative strengths of each metric 
while accounting for potential bias in the case data. Similar modelling approaches combining large 
datasets of different malaria metrics may be applicable across sub‑Saharan Africa.
Malaria is a major public health problem in Madagascar, with an estimated 2.16 million cases leading to more 
than 5000 deaths in the country in  20181. Malaria burden decreased in the early 2000s with an increase in con-
trol efforts but this progress was largely halted following political turmoil in  20092–4 resulting in a resurgence in 
endemicity in the last  decade1,4–6. Transmission exhibits strong spatial trends, with high endemicity in the coastal 
regions and lower transmission in the highlands, and seasonal patterns in incidence are widely  observed4,5. An 
accurate understanding of spatiotemporal variation in transmission can facilitate strategic resource allocation 
and evaluation of control  measures1,4,7.
Routine malaria case data are collected through the Health Management Information System (HMIS) from 
reports from health facilities. These data are collected monthly and have a high spatial coverage (see Fig. 2) but 
also suffer from a number of potential biases. This passive case detection is unlikely to capture all malaria cases 
in the community, missing those that do not seek care or do so from informal or private providers, which likely 
represents a large fraction of the population (treatment-seeking rates in the public sector in 2013 were estimated 
to be around 45%)8–10. Furthermore, cases seen at health facilities may not be diagnosed or reported to the central 
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system due to resource constraints (such as malaria rapid diagnostic test (RDT) stock-outs) or weak communica-
tion  infrastructure4. Nevertheless, while these data may not represent all malaria incidence, they are an important 
source of information on trends in transmission due to their high temporal and spatial  coverage4,6,11–13.
Malaria Indicator Surveys (MIS) provide another source of data for understanding the spatiotemporal pat-
terns of malaria  endemicity9,10,14. These cross-sectional surveys are designed to be nationally representative and 
collect data on a number of indicators, including prevalence of Plasmodium falciparum infection in individuals 
between 6 and 59 months of age. They are conducted with a standardised methodology applied over all sites 
and surveys and, unlike routine case data, are not affected by reporting incompleteness, treatment-seeking 
behaviour or standards for clinical diagnosis. For these reasons, prevalence information from national health 
surveys has traditionally been the primary source of data for mapping malaria risk in sub-Saharan  Africa3,5,15,16. 
Kang et al.5 used a Bayesian hierarchical model to map prevalence in Madagascar in 2011, 2013 and 2016 using 
parasite prevalence data from the 2011, 2013 and 2016 MIS  reports9,10,14. However, cross-sectional surveys pro-
vide limited insight into seasonal patterns of transmission or transmission in years when no survey took place. 
Variation in the timing of surveys between years may also make it difficult to distinguish changes in prevalence 
between survey years from seasonal variation. Moreover, survey data is less informative in low burden areas, 
where sample sizes are likely to be inadequate to accurately assess changes in transmission due to low rates of 
detectable  parasitaemia17.
In this study, we combined routine case data and prevalence survey data within a formal modelling frame-
work, taking advantage of their relative strengths, in order to provide a more complete understanding of the 
spatiotemporal heterogeneity of transmission between 2013 and 2016. One method for combining prevalence 
and incidence data is to use a joint model, a single model which includes the likelihoods of both metrics and the 
relationship between  them18–20. These models allow for sharing of information between metrics and produce 
predictions of both incidence and prevalence. However, balancing this sharing of information can be challeng-
ing, particularly in situations where one response variable has many more observations (and therefore a much 
greater likelihood contribution) than the  other20,21. Moreover, there is limited scope to learn the relationship 
between response variables without introducing too many degrees of freedom and therefore this relationship 
is often fixed or highly constrained. Lucas et al.19, for example, modelled malaria prevalence and incidence 
jointly using a fixed previously estimated  relationship22. To allow us to learn the relationship between incidence 
and prevalence and control the relative effect of each metric on the final results, we used a two-step process 
in which we produced spatially smooth monthly incidence surfaces which were then used as a covariate in a 
Bayesian geostatistical model of prevalence. This method is conceptually simpler than a joint model and allows 
the incidence-to-prevalence relationship to be learned within the prevalence model. An important benefit of 
learning this relationship is that systematic biases in routine case data are implicitly accounted for. Modelling the 
incidence and prevalence processes separately is equivalent to making a ‘cut’ between the incidence and preva-
lence processes in the model. Modularising the inference in this way prevents over-reliance on the less reliable 
incidence data in the final prevalence  estimates20,21. This approach is similar to the use of modelled surfaces, such 
as temperature  suitability23 or  accessibility24, as inputs when mapping malaria  risk3,5,15,16. It is also similar to the 
work of Lucas et al.25 who used modelled prevalence surfaces as inputs to an incidence model. However, their 
prevalence model used environmental and socioeconomic covariates and therefore overall this approach was 
equivalent to a non-linear model of incidence using these covariates. In contrast, due to the high spatiotemporal 
coverage of the routine case data, our incidence surfaces are a direct smoothing of treatment-seeking adjusted 
observed incidence rates and therefore represent malaria risk more directly.
We incorporated routine case data to update the estimates of prevalence for 2013 and 2016 made by Kang 
et al.5 and to produce estimates for 2014 and 2015. By producing monthly prevalence maps over all four years, 
both long term and seasonal trends in prevalence across the country could be assessed. We used the eight eco-
zones identified by Howes et al.4 as a basis for assessing how these trends vary spatially.
Methods
Study area. Malaria transmission is highly heterogeneous across Madagascar, reflecting the diverse eco-
logical landscape of the island. Transmission is highest in the east and west coastal regions, where it follows a 
seasonal pattern with clinical incidence peaking between February and May depending on location. In the cen-
tral highlands and the desert south, transmission is lower and annual trends are less consistent, with temporal 
variation appearing to be driven by outbreak  dynamics4,11,26. Howes et al.4 identified eight contiguous ecozones 
representing distinct transmission settings (Central highlands, Highlands fringe west, Highlands fringe east, 
Northeast, Northwest, Southeast, Southwest, South) which are shown in Fig. 1a. When devising the 2018–2022 
malaria National Strategic Plan, the National Malaria Control Programme (NMCP) of Madagascar classified 
106 of the 114 districts in Madagascar as control areas, 3 pre-elimination and 5 elimination, based on reported 
case numbers in  20167. Control strategies are currently stratified by risk level, with intermittent preventative 
treatment for pregnant women (IPTp) and mass distribution of insecticide-treated bed nets (ITNs) in the 106 
control districts and indoor residual spraying (IRS) targeted at high transmission districts in the southeast and 
southwest. In pre-elimination settings the focus is on outbreak and active case  detection27,28.
Study data. Parasite prevalence data was available from Malaria Indicator Surveys that took place in Mada-
gascar in 2013 and 2016. These data consist of geo-located clusters where the prevalence of P. falciparum infection 
was measured, determined by microscopy, in individuals between 6 and 59 months of age ( PfPR6−−59months ). 
These surveys were conducted with a standard protocol and survey sites were selected to produce nationally 
representative estimates of prevalence in this age group. The number of positive individuals and the total number 
tested was recorded at each site. In the 2013 and 2016 surveys, 6323 and 6927 individuals were screened across 
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274 and 358 sites, respectively. The survey sites and proportions of positive individuals are shown in Fig. 1b and 
full details can be found in the original  reports9,10.
Monthly health facility case data between January 2013 and December 2016 were provided by the NMCP. 
These data come from HMIS data reports and represent clinical cases of malaria confirmed by an RDT for all 
ages, irrespective of parasite species. Data were available from 3342 health facilities in Madagascar, of which 2801 
were geo-located and verified using a separate dataset of geo-located health facilities from the Institut Pasteur 
de Madagascar (as described  in11).
A number of covariates were used to inform the prevalence model, which are detailed in Table 1. Most of these 
variables were environmental, influencing vector abundance, parasite behaviour and environmental suitability. 
Two of these covariates (accessibility to  cities24 and night  lights30) relate to the development and urbanicity of a 
location and therefore are related to vector abundance and to socioeconomic factors, such as access to healthcare. 
In total there were 26 potential features for the prevalence model—8 static covariates and 6 dynamic covariates, 
each considered at 0, 1 and 2 month time lags. Causal feature  selection31 was used to select the variables included 
in the final model.
Catchment population. In order to calculate incidence rates at each health facility, estimates for catch-
ment populations (the number of people likely to seek treatment at each facility) were needed. A catchment 
model was used to estimate these (treatment-seeking) catchment populations, based on travel time to health 
facilities. The country was divided into a grid of approximately 5 km-by-5 km pixels. For each pixel, the travel 
time to each health facility was calculated using a friction surface (defining travel time through each pixel) 
developed by Weiss et al.24 and a least cost  algorithm39. Given that an individual in pixel i seeks treatment, the 
Figure 1.  (a) Ecozones defined by Howes et al.4 representing contiguous areas with distinct patterns of 
transmission. (b) Prevalence rates at survey sites in the 2013 and 2016 MIS. These maps were created in R 
(version 3.6.2, https ://www.r-proje ct.org/) using the  ggplot229 package.
Table 1.  List of covariates.
Covariate Description Type In any causal feature set In final feature set
Rainfall32 Climate hazards group infrared precipitation with station data Dynamic Lag 0 Lag 0
LST  day33 Daytime land surface temperature Dynamic No No
LST  night33 Night-time land surface temperature Dynamic Lag 1 No
TCB34 Tasselled cap brightness; measure of land reflectance Dynamic Lag 2 No
EVI35 Enhanced vegetation index Dynamic No No
TSI  Pf23 Temperature suitability index for P. falciparum Dynamic Lag 2 No
Accessibility24 Distance to cities with population > 50,000 Static Yes Yes
AI36 Aridity index Static Yes Yes
Elevation37 Elevation as measured by the shuttle radar topography mission (SRTM) Static Yes No
PET36 Potential evapotranspiration Static Yes No
Slope37 GIS-derived surface calculated from SRTM elevation surface Static Yes No
Night  lights30 Index that measures the presence of lights from towns, cities and other sites with persistent lighting Static No No
Distance to  water38 GIS-derived surface that measures distance to permanent and semi-permanent water based on presence of lakes, wetlands, rivers and streams, and accounting for slope and precipitation Static Yes Yes
TWI37 Topographic wetness index Static No No
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probability they seek treatment in health facility j, p(pixeli → HFj) , was modelled as inversely proportional to 
square of the travel time to that health facility. That is,
where t(pixeli → HFj) represents the travel time from pixel i to health facility j and NHF was the total number 
of health facilities. The catchment population of health facility j was then calculated as
where populationi is the treatment seeking-adjusted population of pixel i and Npixel is the total number of pixels. 
The proportion of the population in each pixel who would seek treatment at any health facility was also modelled 
as a function of travel time, which has been identified as an important factor in treatment-seeking behaviour 
for fever in  Madagascar40. This proportion was modelled as a logistic function (similar to the functional forms 
considered by Alegana et al.41)
where t is the travel time to the nearest health facility in minutes. The parameters values α = 0.6 , σ = 0.00916 , 
β = 0.15 were chosen such that the maximum and minimum possible treatment-seeking proportions were 0.6 
and 0.15, and the treatment-seeking proportion at t = 120 minutes was 0.3. These parameter values were chosen 
to produce a similar relationship between treatment-seeking and travel time as that observed in the 2013 and 
2016  MISs9,10 (see Supplementary Material Fig. 3) and match overall estimated treatment-seeking  rates8. Catch-
ment populations were calculated for each year between 2013 and 2016 using hybrid population surfaces from 
the Gridded Population of the World  v442 and  WorldPop43. In order to assess the sensitivity of the final estimates 
to these modelling assumptions, three alternative sets of populations were considered: catchment populations 
supplied by the NMCP (based on the 1993 national census adjusted by a fixed annual growth  rate44 with no 
adjustment for treatment-seeking behaviour) and two sets of catchment populations generated by the catchment 
model under different treatment-seeking parameters (see Supplementary Material). The analysis was repeated 
using these catchment populations and the resulting prevalence estimates were compared.
Incidence model. Routine case data from health facilities were modelled using a Bayesian geospatial model 
to produce monthly incidence surfaces which were then used as inputs to the prevalence model. Let cit be the 
number of cases observed in month t ( t = 1, …, 48) at health facility i (i = 1, …, N), which is at location si and has 
a treatment-seeking catchment population Ei . The number of cases observed was modelled as a Poisson process
with mean equal to the product of the catchment population and the underlying incidence rate, it . The log 
incidence rate was modelled as
where β0 was an intercept and for each month f (·, t) was a realisation of a Gaussian process over space with zero 
mean and Mátern covariance structure. The Mátern covariance function is parameterised by the range, ρ , and 
marginal variance, σ 2 , the values of which were chosen by a search over parameter space to maximise accuracy 
when predicting incidence in held out locations. These parameters were optimised jointly over all months. The 
value of smoothness parameter, ν , was fixed at 1.
Prevalence model. Prevalence data from MIS surveys were also modelled using a Bayesian geospatial 
model, informed by environmental and socioeconomic covariates and the modelled incidence surfaces. Let yi 
be the number of infected individuals and Ni be the number of individuals tested in survey i ( i = 1 , …, M), tak-
ing place in location si at time ti . The results of the survey were modelled as a realisation of a binomial process
with underlying prevalence pi at this location and point in time. The logit-transformed prevalence was modelled 
as
where β0,β ,β inc0 ,β
inc
1  were parameters (with β
inc
0  and β
inc
1  non-negative), X i were covariate values and (s, t) was 
the log incidence value from the modelled incidence surfaces at location s and time t. f was modelled as a realisa-
tion of a Gaussian process over space with Mátern covariance, parameterised by the range ρ and marginal vari-
ance σ 2 , while g is a realisation of a Gaussian process over incidence with a squared exponential kernel, param-
eterised by the scale κ (with fixed variance 1). This allowed a non-linear effect of incidence on logit-prevalence 
while limiting model-complexity by assuming a priori that this relationship is smooth (by the choice of squared 
exponential kernel and placing an appropriate prior on the scale parameter). This flexibility was important as 












cit ∼ Pois(Ei × it)
log it = β0 + f (si , t)
yi ∼ Binomial(pi ,Ni)
logit(pi) = β0 + β
T
X i + β
inc
0 g((si , ti))+ β
inc
1 g((si , ti + 1))+ f (si)
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incidence is likely to be the main driver of prevalence in the model (while the additional covariates are likely to 
be less informative and therefore were modelled as having linear effects) and assuming a linear effect produces 
prevalence-incidence relationships that do not match empirical  observations22. Incidence in the subsequent 
month was included in addition to incidence in the current month, as the presence of parasites in the blood 
could result in a clinical case that is recorded in a health centre several weeks later. The parameters β inc0  and β
inc
1  
allowed the model to learn the relative predictive power of incidence at these two time points.
The Bayesian model was completed by placing appropriate priors on the parameters and hyperparameters. 
Normal priors were placed on β0,β ,β inc0 ,β
inc
1  centred around 0 with standard deviation 1 for β0 and 0.25 for 
β ,β inc0 ,β
inc
1  . The Mátern covariance parameters were given log-normal priors with mean 3 and standard devia-
tion 0.1 for ρ and mean 0 and standard deviation 0.1 for σ , shrinking the spatial term towards a fairly flat and 
smooth field. A log-normal prior was placed on κ with mean 3 and standard deviation 0.1. Both the incidence 
and prevalence models were fitted using the Gaussian Markov Random Field  approximation45 with the Template 
Model Builder  package46 in R47 and samples were drawn from a Laplace approximation to the posterior to pro-
duce associated uncertainty estimates. Uncertainty was quantified using the interquartile range of the posterior 
distribution and exceedance and non-exceedance probabilities. For a given prevalence threshold, the exceedance 
probability at a location is defined as the probability that a prevalence sample from the posterior at this location 
will exceed the threshold. Similarly, a non-exceedance probability is the probability a prevalence sample will not 
exceed a given value. The model was validated by fitting the model with data from the 2013 survey and making 
predictions for 2016 (to evaluate model performance when predicting prevalence in previously unobserved time 
points) and through k-fold cross validation.
Feature selection. The covariates included in the prevalence model were selected from the potential covar-
iates described in Table 1 using causal feature  selection31,48. In total there were 26 potential features, 18 dynamic 
(6 covariates each at 0, 1 and 2 month time lags) and 8 static. The idea behind causal feature selection is to select 
features with the most direct causal relationships to the response based on the available data.
We describe the procedure briefly here which is described in full detail by Arambepola et al.31. The PC 
 algorithm49, a causal discovery algorithm, was used to infer causal relationships between the different features 
and malaria prevalence. In particular, the output of this algorithm identified all direct causes of prevalence. To 
quantify the certainty of these direct causes, the algorithm was repeatedly applied to bootstrapped samples of 
the data. The certainty of a feature being a direct cause of prevalence was then quantified as the proportion of 
repeats in which it was inferred to be a direct cause. For a given minimum certainty, feature sets were then gener-
ated by selecting all direct causes of prevalence and a number of potential feature sets were generated by varying 
the minimum certainty required between 0 and 1. Out of these potential feature sets, the final set chosen was 
the feature set which maximised the cross-validated predictive performance of the model. The causal discovery 
algorithm relies on conditional independence testing. We used the Randomized Conditional Independence  Test50 
to perform scalable non-parametric conditional independence tests.
Selecting causal features may be beneficial for a number of reasons. It is possible that causal selection may 
lead to smaller feature sets, especially in situations in which many features are associated with the response vari-
able but relatively few are directly  causal48. Small feature sets may improve computational efficiency and reduce 
overfitting. Models built on causal feature sets may also be more robust to common problems such as concept 
drift and covariate  shift51 and therefore make more useful predictions further forward in time or in previously 
unobserved locations. Arambepola et al.31 showed that using causal feature selection resulted in improved per-
formance when forecasting malaria incidence compared to classical feature selection.
Results
Catchment populations. The median size of the modelled catchment populations was 2890 (LQ: 1710, 
UQ: 4740). The total population served according to the modelled populations increased from 10.15 million in 
2013 to 11.02 million in 2016, corresponding to approximately 43% of the Malagasy population each year, which 
is largely in agreement with estimated treatment-seeking  rates8.
Incidence. Annual incidence rates at each health facility (calculated using reported cases and modelled 
catchment populations) are shown in Fig.  2. Spatial patterns of incidence in 2013 and 2016 were similar to 
observed prevalence (Fig. 1b) with lower rates in the central highlands and the south, and higher rates in the east 
and west coastal regions. Compared to 2013, incidence in 2016 was generally higher in health facilities in the 
southeast and southwest but lower in the north. Across the 4 years, rates were generally lowest in 2014 (with the 
exception of the east coast) and highest in 2015. Figure 3 shows monthly incidence rates aggregated by ecozone. 
A seasonal pattern of a single peak in incidence between January and April can be seen to some extent in most 
regions, most clearly in the Southeast, Northeast and (despite low overall incidence) Highland fringe east ecoz-
ones. An increase in cases in 2015 was observed in almost all ecozones.
The optimal hyperparameters for the incidence model were ρ = e−0.1 and σ = e−2 . Supplementary Material 
Fig. 4 shows the smooth incidence surfaces produced by this model aggregated annually, which as expected reflect 
the overall spatiotemporal trend of the observed data. It should be noted that these surfaces were only intended to 
be a spatial smoothing of the treatment seeking-adjusted case data reflecting relative spatial trends, rather than an 
enumeration of true incidence rates, and are an intermediate step in the modelling process rather than an output.
Prevalence. The causal discovery algorithm identified 4 dynamic and 4 static feature sets which combined 
to give 16 potential feature sets for the prevalence model. The features that were present in at least one of these 
sets are listed in Table 1 and these sets are listed in full in the Supplementary Material. The features used in the 
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final model were  rainfall32 with no time lag, accessibility to  cities24, an aridity  index36 and distance to  water38. The 
posterior mean and 95% credible interval for all the model parameters, including coefficients of these features, 
are shown in Table 2. As expected, incidence was the most important predictor, with incidence in the current 
month having a greater effect than incidence in the following month. The other covariates in the model had 
smaller and less consistent effects on prevalence. When fitting the model on 2013 data and making predictions 
for 2016, there was a correlation of 0.63 between predicted and observed values. For 3, 4 and 5-fold cross-vali-
dation, there were average correlations of 0.58, 0.59 and 0.6, respectively. These values are reasonably high given 
that the observed prevalence rates are themselves noisy point estimates of underlying prevalence; for context, the 
standard errors of the mean of binomial samples of 20 individuals (the median survey size) with true prevalence 
values of 0.01, 0.05 and 0.15 are 0.022, 0.049 and 0.080, respectively.
Prevalence estimates for individuals between 6 and 59 months of age are shown aggregated annually in Fig. 4a. 
Spatial patterns were similar across all four years, with highest estimated prevalence near the southeast coast and 
other areas of high prevalence along the west coast. Prevalence estimates were consistently low in the far south 
of the country and in the central highlands. Prevalence in the north varied more between years, although was 
generally low or moderately low. Population-weighted mean prevalence was lowest in 2014 (6.0%, 95% credible 
interval (CI) 3.3–8.8), followed by 2013 (6.4%, CI 3.5–9.5) and 2016 (6.6%, CI 3.6–9.6), and was highest in 2015 
(8.9%, CI 4.6–12.9). Population-weighted prevalence over time (Fig. 4b) showed a clear seasonal pattern, peak-
ing between February and April each year with the lower prevalence occurring between July and September. 
Prevalence was highest in 2015, with the peak prevalence across all four years occurring in April 2015 (11.4%, 
CI 5.8–16.0) and notably high prevalence sustained into the lower transmission season. By the second half of 
2016, prevalence appeared to have returned to similar levels to 2013 and 2014.
Figure 5 shows the mean prevalence over time for each ecozone. Prevalence was consistently highest in the 
Southeast ecozone, with peak monthly prevalence of 0.3 or more in all years, while consistently lowest in the 
Central highlands and Highland fringe east ecozones. Seasonal patterns of prevalence are present in most of 
these ecozones, including both higher transmission regions (Northeast, Southeast and Southwest) and the lower 
transmission highland ecozones. These regional seasonal trends are similar to the pattern observed for mean 
prevalence across the country, with a single peak occurring between February and April in most areas (though 
often earlier in the Southeast ecozone) and lowest prevalence around August. The Northwest and South ecozones 
exhibit some similar seasonal trends but these are less consistent. In most areas, prevalence in 2014 was slightly 
lower than in 2013, with large decreases in the Northwest and South ecozones. Increased prevalence in 2015 was 
observed in all areas. In the highland ecozones, prevalence was higher than normal around April but later in the 
year returned to similar levels to previous years. In the rest of the country, a high peak in April was generally 
followed by higher than average prevalence throughout the rest of the year and into 2016. The ecozones generally 
correspond well to these latest prevalence estimates (Supplementary Material Fig. 5 shows the 2016 estimates 
with ecozone borders highlighted). The greatest heterogeneity within ecozones was in the Highland fringe west 
ecozone, which contained a region of higher prevalence to the south, and the Northwest ecozone.
Monthly prevalence estimates can also be used to identify areas where transmission is consistently low or high. 
Two examples are shown in Figure 6 for estimates of prevalence in 2016. Figure 6a shows areas where prevalence 
was always below 5% or below 5% for at least 9 months and Fig. 6b areas where prevalence was always above 
20% or above 20% for at least 6 or 9 months. Despite the seasonal trends in transmission (Fig. 5), in much of the 
central highlands prevalence was below 5% year-round, while some areas in the western highlands only exceeded 
5% for at most 3 months of the year. Transmission was also consistently low in parts of the desert south and far 
north of the country. The areas of consistently high prevalence were concentrated on the east and southwest 
coasts, following a similar pattern to overall prevalence.
Figure 2.  Annual incidence rates at each health facility based on routine case data and modelled catchment 
populations. These maps were created in R (version 3.6.2, https ://www.r-proje ct.org/) using the ggplot2 package.
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Figure 7 shows two ways of visualising the uncertainty in prevalence estimates, using annual 2016 estimates 
as an example. The first (Fig. 7a) maps the interquartile range of the posterior distribution. The spatial patterns of 
uncertainty are similar to the prevalence estimates, with higher (absolute) uncertainty areas of high prevalence. 
An alternative quantification of uncertainty is in terms of probability of estimates exceeding (or not exceeding) 
chosen values. Figure7b shows the probability of prevalence (sampled from the posterior distribution) exceeding 
0.15. This can be interpreted as the probability that the true prevalence in 2016 exceeded 0.15. In the majority of 
the country there is a very high certainty that prevalence was below 0.15, while on the east and west coasts there 
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Figure 3.  Monthly incidence rates at each health facility based on routine case data and modelled catchment 
populations stratified by ecozone (2013–2016). These graphs were created in R (version 3.6.2, https ://www.r-
proje ct.org/) using the ggplot2 package.
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is fairly high confidence that prevalence exceeded this value. In the southwest, in particular, the probability of 
exceeding 0.15 is often above 90%. Similarly, we can visualise the probability of not exceeding a certain value, as 
shown in Fig. 7c with the probability of not exceeding 0.05. Here we can identify areas in the highlands, south 
and far north where there is very high confidence of low prevalence. We also see more areas around the north 
where there is less certainty, with probabilities between 20 and 50% of prevalence not exceeding 0.05. Maps of 
uncertainty in 2013, 2014 and 2015 using the interquartile range and exceedance probabilities are included in 
the Supplementary Material (Supplementary Material Figs. 5–7).
The sensitivity analysis performed using different catchment populations showed that our prevalence esti-
mates were fairly robust to different methods of estimating these populations. Despite the systematic differences 
between these estimates, leading to significantly different incidence estimates (Supplementary Material Fig. 1), 
the resulting prevalence estimates were very similar (Supplementary Material Fig. 2).
Discussion
Our results highlight the benefits of combining routine case data and cross-sectional survey data to provide a 
more complete understanding of prevalence over time. While the 2013 and 2016 MIS data show similar levels of 
prevalence in these 2 years, the routine case data suggests there was substantial variation in transmission between 
these time points, with decreasing case numbers in 2014 followed by a marked increase in 2015. Incorporating 
this case data into a formal modelling framework allowed us to quantify these trends in terms of changes in 
prevalence over time. The robust two-step modelling approach allowed us to learn from these noisy data sources 
effectively while retaining flexibility in important model components, in particular the incidence-to-prevalence 
relationship.
By producing monthly risk maps we are able to assess temporal trends of interest in detail. For example, in 
much of the country the increase in prevalence in 2015 was caused by increased prevalence throughout the year 
and into early 2016, rather than only higher than average prevalence during the high transmission season. The 
observed increase in cases in 2015 has been attributed to cyclones and the resulting flooding and lack of supplies 
in many parts of the  country52. Our results may help confirm this or identify other factors driving these increases 
in transmission (and similarly the decreases in 2014). We can also distinguish regions where prevalence appears 
to have returned to normal levels by the second half of 2016 from regions where increased transmission appears 
to have been sustained, such as the South and Highland fringe west ecozones. The latter may be potential targets 
for increased control efforts. Monthly prevalence estimates allowed us to evaluate seasonal trends in prevalence. 
These trends were largely similar across the country, with one seasonal peak occurring between February and 
April. This seasonality was clear in many of the high transmission areas but was also observed in highland 
ecozones, despite the low overall prevalence in these regions. A better understanding of baseline transmission 
patterns in low transmission settings may improve outbreak  detection26 or influence plans for moving towards 
pre-elimination and elimination in these areas.
Identifying areas of consistently low or high transmission may also influence operational planning. Currently 
ITN mass distribution campaigns (MDCs) are carried out everywhere except elimination and pre-elimination 
districts. The criteria for this stratification are annual incidence and test positivity rates (elimination districts 
are defined by an incidence rate of less than 1 per 1000 people and pre-elimination by an incidence rate between 
1-10 and less than 5% test positivity)7. Use of monthly prevalence estimates could help to distinguish areas that 
have consistently low transmission (as identified in Fig. 6a) from low transmission areas with short but significant 
seasonal peaks which could benefit from more intervention. Similarly, highlighting areas with consistently high 
prevalence could inform the control methods used in these areas.
We can also consider the long term trends over the four years in the context of the MDCs which have taken 
place approximately every three years since  200928. The second MDC took place in November 2012 on the 
east coast and October 2013 in the rest of the country and the third from September to December  201553,54. 
Although continuous ITN distribution was carried out to supplement these campaigns, a decline in net coverage 
and effectiveness over time could be a factor in the overall increase in estimated burden up to the end of 2015.
When comparing our results to the MIS data, the prevalence estimates from the MIS reports of 9.1% in  20139 
and 7.0% in  201610 are higher than our annual point estimates (6.4% and 6.6% respectively) but are consistent 
Table 2.  Mean and 95% credible intervals for the prevalence model parameters
Parameter Mean CI
Intercept − 3.956 − 6.082, − 1.926
Accessibility 0.060 − 0.021, 0.150
AI − 0.066 − 0.172, 0.042
Distance to water − 0.031 − 0.108, 0.042
Rainfall (no lag) 0.019 − 0.097, 0.128
log ρ 1.48 1.263, 1.693
log σ − 0.762 − 0.968, − 0.561
log inc 1.883 0.881, 3.043
β inc0 0.802 0.407, 1.22
β inc1 0.497 0.184, 0.879
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with our credible intervals. However, our results show limited evidence of a decrease in prevalence in 2016 
compared to 2013. It appears likely that the decrease observed in the raw data is a consequence of the timing of 
the 2016 survey which primarily took place between May and July, around a month later than the 2013 survey 
and slightly past the seasonal peak in prevalence for the year. The annual 2013 and 2016 risk maps made by Kang 
et al.5 show a similar spatial pattern to our results, with low rates of prevalence in the highlands and south of the 
country and higher rates in the east and west coasts. However, Kang et al.5 estimate high prevalence in the north 
of the country, whereas in our results areas of higher prevalence are largely in the northeast. Similar to our results, 
their estimates show very similar prevalence in 2013 and 2016, although in general the overall mean estimated is 
slightly higher (9.3% in 2016) than our point estimates. We can also compare the monthly estimates of prevalence 
in each ecozone. While in many regions overall seasonal trends were largely similar, the monthly prevalence 
estimates made by Kang et al.5 show less consistent seasonal patterns with greater uncertainty. We would expect 
the monthly estimates in our analysis to be more robust, particularly outside of the survey months (April–June 
in 2013 and May–July in 2016) and in lower transmission areas, as there is more data to inform each month.
Figure 4.  Prevalence estimates for individuals between 6 and 59 months of age, (a) aggregated annually and (b) 
population-weighted mean over time with 95% credible intervals. These plots were created in R (version 3.6.2, 
https ://www.r-proje ct.org/) using the ggplot2 package.
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Comparing prevalence estimates to the routine case data, we can see that the temporal patterns in prevalence 
are typically smoothed trends from the case data (due to the spatial smoothing when producing the incidence 
surfaces and the temporal smoothing from using incidence at two time points to the predict prevalence). How-
ever, we can see distinct spatial trends in the prevalence estimates, for example prevalence was consistently 
highest in the Southeast ecozone in the whole study period despite similar or higher observed incidence rates 
in the Southwest ecozone from April 2015 onwards.
As well as visualising uncertainty using the interquartile range, we have used maps of exceedance (and 
non-exceedance) probabilities. In practice, the latter may be more interpretable and therefore more useful for 
communicating uncertainty. By choosing relevant thresholds, exceedance surfaces may be useful for identify-
ing areas that are estimated to be high transmission with high confidence or areas that are most likely to be 
considered pre-elimination.
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Figure 5.  Population-weighted mean prevalence over time stratified by ecozone with 95% credible interval. 
These graphs were created in R (version 3.6.2, https ://www.r-proje ct.org/) using the ggplot2 package.
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Limitations. A key modelling input in this study was monthly incidence rates at each health facility, which 
depend on the estimated catchment populations. Our model for estimating these catchment populations is 
based only on travel time to each health facility and does not take into account other factors that may influence 
treatment-seeking or choice of facility, such as type of  facility40,55. However, the results of our analysis when 
using catchment population estimates from the NMCP and when varying treatment-seeking behaviour (see 
Supplementary Material Figs. 1 and 2) demonstrate that our modelling approach is fairly robust to differences 
in catchment population estimates. This is likely due to the spatial smoothing of incidence data and learned 
incidence-to-prevalence relationship. Treatment-seeking behaviour may also vary throughout the year, which 
is not accounted for in this analysis and may bias monthly estimates of prevalence. Modelling these temporal 
dynamics is extremely challenging, with limited treatment-seeking data available and behaviour that is likely to 
vary on a small spatial scale based on local infrastructure and geography.
A strength of our approach is the ability to account for bias in reporting of case information due to the learned 
relationship between prevalence and incidence. However, differences in reporting across the country cannot be 
accounted for in this relationship (which is constant across time and space). Howes et al.4 investigated the spatial 
variation in reporting in 2014 by looking at RDT stock-outs and proportion of distributed RDTs for which any 
result was reported to the HMIS by district. The proportion of RDT results reported was generally higher on the 
west coast, and therefore prevalence in this region may be somewhat overestimated, but across the rest of the 
country there were no strong spatial trends in reporting. Similarly, increases in reported cases over time may be 
partly due to increased access to healthcare or availability of RDTs, leading to overestimates of prevalence in more 
recent years, although the use of survey data in the first and last years of our study period should mitigate this.
Figure 6.  Number of months in 2016 with estimated prevalence (a) below 5% and (b) above 20%. These maps 
were created in R (version 3.6.2, https ://www.r-proje ct.org/) using the ggplot2 package.
Figure 7.  Uncertainty in 2016 annual prevalence estimates expressed with (a) interquartile range, (b) 
probability of prevalence exceeding 0.15 and (c) probability of prevalence not exceeding 0.05. These maps were 
created in R (version 3.6.2, https ://www.r-proje ct.org/) using the ggplot2 package.
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Although the case data used in this study was for a different age range (all ages) to the estimates of prevalence 
(6–59 months), we believe this is unlikely to bias our estimates. There was a strong relationship between the 
number of cases in individuals under 5 and all ages in the routine case data (correlation of 0.91 across all health 
facilities and months) and the relationship between incidence and prevalence was learned within the model. 
Therefore we would expect the predictive power of incidence in either age range to be similar. Incidence for 
all ages was chosen due to the larger sample sizes in the data, which should produce more reliable estimates of 
incidence.
The aim of this study was to estimate prevalence, however estimates of incidence may be of more use for public 
health purposes (for example, district-level risk stratification by the NMCP is based on estimated  incidence7). 
Future work could therefore focus on mapping incidence. A common approach for generating incidence esti-
mates is to use prevalence estimates and an established prevalence–incidence  relationship3,16. This approach is 
generally used where prevalence estimates are informed only by prevalence survey data (where routine case 
data is unavailable or too unreliable to be used) but a similar transformation could be applied to the prevalence 
estimates produced here. A more direct way of combining routine case data and survey data to estimate incidence 
would be to use a joint  model19. To do so successfully would likely require a more complete understanding of 
the spatiotemporal trends in treatment-seeking and reporting completeness in order to account for bias in the 
routine case data due to these factors.
Conclusion. In this study, we used routine case data and survey data to produce monthly estimates of malaria 
prevalence between 2013 and 2016. Our results suggest that while malaria endemicity was similar in 2013 and 
2016, there was considerable variation in the intervening period, with a small decrease in 2014 followed by a 
substantial increase in 2015. In many areas, this increase in prevalence was sustained throughout 2015 and early 
2016, and in the Northwest and South ecozones prevalence had yet to return to 2014 levels by the end of 2016. 
Considering these temporal trends at specific locations in relation to the timing of control efforts (such as ITN 
distribution) and climatic events may help to identify drivers of transmission and assess intervention effective-
ness. Areas where prevalence remains higher than pre-2015 levels could be targets for increased control meas-
ures. Seasonality of transmission (with a single peak around March) was widely observed in high transmission 
areas and in some low transmission areas. The relative spatial patterns of prevalence were mostly consistent over 
time, with highest prevalence in the southwest and high prevalence in the southeast. Prevalence was consistently 
low in the highlands and in parts of the south of the country.
The Bayesian modelling approach applied here allowed us to make prevalence estimates with associated 
measures of uncertainty by learning temporal trends in transmission from the routine case data and calibrating 
these trends to prevalence observations from the survey data. These risk estimates could be an important tool 
for assessing the impact of control measures and the progress made towards the goals set out by the  NMCP27,28 
and for better understanding the drivers of changes in transmission. Our results demonstrate the considerable 
additional information that can be gained by combining data sources in this way. While previous risk mapping 
efforts produced monthly prevalence maps for 2011, 2013 and  20165, these were informed by a relatively small 
number of prevalence observations from surveys which only covered 3 months of each year. We were able to make 
monthly maps of prevalence over a four year period (including years in which no surveys took place), informed 
by a large amount of monthly case data in addition to the survey data. By using a two-step modelling approach, 
rather than a joint likelihood model, we were able to learn the relationship between incidence and prevalence 
within the model (thereby accounting for systematic under reporting in the case data) and ensure that the model 
was informed by the more reliable prevalence data, despite the relatively small number of observations compared 
to the case data. Our sensitivity analysis demonstrated that these estimates are robust to varying assumptions 
about treatment-seeking behaviour and reporting incompleteness. A similar modelling strategy may be effective 
in other multi-metric disease modelling settings, especially where there is an imbalance between the number of 
observations or reliability of different metrics.
Incomplete reporting, treatment-seeking behaviour, and inconsistent standardisation of clinical diagnoses 
affect the quality of routine case data in many countries of sub-Saharan  Africa56. Consequently, the World 
Health Organization estimates for malaria burden are often based on community prevalence surveys  alone1,24. 
The methods presented here may be a useful starting point for incorporating routine case data into estimates of 
malaria burden more widely.
Data availability
Prevalence datasets, sample case data, and code are available at https ://githu b.com/raram bepol a/Preva lence 
-Madag ascar . The raw case data that support the findings of this study are available from the Programme National 
de Lutte Contre le Paludisme de Madagascar and the Institut Pasteur de Madagascar (IPM).
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